An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal Cancer

ABSTRACT: This observational study will assess the progression-free survival, overall response and safety of Avastin (bevacizumab) in combination with chemotherapy in a real life setting in patients with metastatic colorectal cancer. Data will be collected from patients for approximately 2 years.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2100034 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR